Drug Use Investigation of Zevalin.

Trial Profile

Drug Use Investigation of Zevalin.

Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2018

At a glance

  • Drugs Ibritumomab tiuxetan (Primary)
  • Indications B cell lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
  • Focus Adverse reactions
  • Acronyms ZEVALIN-DUI
  • Sponsors Bayer; Spectrum Pharmaceuticals
  • Most Recent Events

    • 09 Nov 2011 Additional trial acronym ZEVALIN-DUI identified as reported by ClinicalTrials.gov.
    • 10 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top